Interview with Sammy Danso

What is your current role in EPAD? I am the resident Data Scientist based at the University of Edinburgh and I work closely with the International Coordinator for EPAD work package 4. The work package 4 includes the Longitudinal Cohort Study, which involves collecting and managing all the datasets that are collected from different sources…

Interview with Marija Jovanovic

What is your current role in EPAD? I joined EPAD in October 2018 and am assigned as a lead EFPIA partner responsible for oversight of the Longitudinal Cohort Study (LCS), working alongside the Chief Investigator office at UEDIN.  I am a member of Work Package 4, currently leading the LCS Recruitment Core Team and am…

Spotlight on Grampian

This month, we get to know the Grampian centre behind EPAD. The Grampian (that is in North East Scotland!) EPAD trial delivery centre enrolled its first research participant in May 2018. The small but efficient team of six led by Dr. Alasdair Lawrie (principal investigator of EPAD in Grampian) had recruited 22 participants in the…

Interview with Alejandro Laquidain

Alejandro Laquidain is one of the more than 200 Spanish research participants of the EPAD project recruited within the research center of the Pasqual Maragall Foundation (Barcelona, Spain), the Barcelonaβeta Brain Research Center (BBRC).   What motivates you to be a research participant in a research project like EPAD? The volunteering proposal presented by the…

EPAD turns four!

Another EPAD year has passed and we are proud to look back at a lot of successful deliveries and established relationships. To celebrate turning four, we look back at some of our key achievements of the past 12 months. January On 16th January, the EPAD Academy officially started its first activity by proposing online webinars…

EPAD publishes its LCS study protocol

  The EPAD project aims to develop an environment for and then test multiple different interventions targeting the secondary prevention of Alzheimer’s disease dementia. EPAD is conducting a Longitudinal Cohort Study (LCS) in alignment with a Bayesian adaptive designed EPAD Proof-of-Concept (PoC) trial. On 27 December 2018, an article presenting the EPAD LCS study protocol…

EPAD welcomes new partner MSD

We are pleased to announce the arrival of a new project partner, MSD (Merck Sharp and Dohme). We say a warm welcome to MSD and look forward to our collaboration. EPAD combines knowledge and expertise from 39 European organisations across multiple sectors, bringing a wealth of experience to our activities. The list of our partners…

Spotlight on Brescia

The EPAD family of trial delivery centres grew to 20 sites in August 2018 with Brescia (Italy) enrolling its first research participant. The team of Dr. Samantha Galluzzi (principal investigator of the EPAD project in Brescia) has currently recruited 15 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with the Brescia team…

Aridhia announces its partnership with Microsoft Azure

On 4 December, our partner Aridhia announced that its digital research platform AnalytiXagility used in the health, biomedical research and precision medicine sectors, is to move all its work to Azure, including treatment studies by the European Prevention of Alzheimer’s Dementia Consortium (EPAD). Aridhia will use Microsoft’s service to offer medical experts, such as those at EPAD,…

Spotlight on Tayside

This month, we get to know the Tayside centre behind EPAD. The site began recruiting in February 2018, with its first participant enrolled on 22nd February. The team has currently recruited 50 participants and still has 6 participants due in for baselines this month, taking the total to 56 participants by the end of November.…